BioPharmSignal logoBioPharmSignal

Biotech News

OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th

OraSure Technologies, Inc. (OSUR)OraSure Technologies, Inc.Earnings

BETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026, after the market closes. It will hold its quarterly conference call to discuss the results beginning

Related news

OSUROraSure Technologies, Inc.2026-07-22 20:10 EST

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

OSUROraSure Technologies, Inc.2026-04-22 20:10 EST

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

XGNExagen2026-10-27 13:00 EST

Exagen to Announce Third Quarter Financial Results on November 10, 2026

SERASera Prognostics2026-10-21 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026

FLGTFulgent Genetics, Inc.2026-10-15 20:05 EST

Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026

LUCDLucid Diagnostics2026-10-29 12:30 EST

Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026

BRLIBio-Reference Laboratories2026-10-28 12:52 EST

OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026

BDSXBiodesix2026-10-22 10:00 EST

Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026

BRLIBio-Reference Laboratories2026-11-04 21:23 EST

OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results

DGXQuest Diagnostics2026-10-22 10:46 EST

Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

View all latest news

OraSure Technologies, Inc.

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient. Rapid-Test Portfolio The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries...

Recent company news

OSUROraSure Technologies, Inc.2026-10-26 20:05 EST

OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th

OSUROraSure Technologies, Inc.2026-08-05 20:05 EST

OraSure Announces Second Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-07-22 20:10 EST

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

OSUROraSure Technologies, Inc.2026-07-21 20:30 EST

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

OSUROraSure Technologies, Inc.2026-06-11 12:00 EST

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

Stock data

Close
3.37 USD
Market cap
275.39M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States